Join
Live feed
·
INSIDERFilingvia Quantisnow
Kiniksa Pharmaceuticals International plc logo

Director Cole G Bradley sold $299,092 worth of Class A Ordinary Share (3,673 units at $81.43) and gifted 4,500 units of Class A Ordinary Share, decreasing direct ownership by 53% to 7,172 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track KNSA (Kiniksa Pharmaceuticals International plc) and more on Quantisnow.

Director Cole G Bradley sold $299,092 worth of Class A Ordinary Share (3,673 units at $81.43) and gifted 4,500 units of Class A Ordinary Share, decreasing direct ownership by 53% to 7,172 units (SEC Form 4) | Quantisnow